Granulomatosis With Polyangiitis
Patients with eosinophilic disorders express diagnosis dissatisfaction online
SAN ANTONIO — Delayed and inaccurate diagnoses often plague patients with eosinophilic disorders, but online communities can help them cope, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
'Advanced vascular imaging' drives revision to ACR/EULAR vasculitis classification criteria
The American College of Rheumatology and EULAR have updated classification criteria for five types of large- and small-vessel vasculitis, driven in part by advances in diagnostic imaging, according to presenters at ACR Convergence 2021.
Rituximab safe for long-term use in granulomatosis with polyangiitis, microscopic polyangiitis
The long-term safety of rituximab was consistent with a shorter duration of treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis, according to data published in Arthritis Care & Research.
Vasculitis guidelines support first-line biologic therapies in certain patients
ATLANTA — Increased use of glucocorticoid-sparing agents is one of the key recommendations in a guideline document that covers seven vasculitis diseases, according to a speaker at ACR/ARP 2019.
FDA expands Rituxan indication for children with vasculitis diseases
The FDA announced the approval of Rituxan injection to treat granulomatosis with polyangiitis and microscopic polyangiitis in children 2 years and older in combination with glucocorticosteroids.